基于信息化的透明监管对耐碳青霉烯肺炎克雷伯菌医院感染的影响：时间序列分析-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

基于信息化的透明监管对耐碳青霉烯肺炎克雷伯菌医院感染的影响：时间序列分析

Impactof information-based transparent supervision on carbapenem-ResistantKlebsiella pneumoniae infection: a time series analysis

ES评分 0 浏览量：637 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20220442
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2022, 6(9)
作者	吴晓琴*,石理冉,路全胜,郭风,阚红侠,
作者单位	江苏省徐州市贾汪人民医院江苏徐州 ;
摘要	探讨基于信息化手段透明监管干预模式在耐碳青霉烯类肺炎克雷伯菌（Carbapenem-resisteant Klebsiella preneumoniae.CRKP）医院感染防控中的应用效果。方法将2020年1～12月某医院46412例住院患者设为干预前组，2021年1～12月的45106例住院患者为干预后组。同时，对医院感染实时监控系统预警的每日检出CRKP菌株患者实施透明监管，借助信息化手段透明公开CRKP感染率、检出率、特殊级碳氢酶烯类抗菌药物使用率,观察透明监管干预前后的效果。结果 2021年1-12月时间序列分析CRKP感染率呈波动式下降，碳氢酶烯类抗菌药物使用率实际值与预测值基本一致，呈总体下降趋势结论借助信息化实时监控系统及时预警CRKP感染病例，加强透明监管CRKP核心防控措施落实及使用信息化平台促进碳青霉烯类药物合理使用的过程控制，可以有效降低CRKP在医院交叉感染及合理使用抗菌药物，保障医疗质量和患者安全。
Abstract	Objective To explore the effect of transparent supervision model on the prevention and control of Carbapenem Resistant Klebsiella Pneumoniae CRKP) nosocomial infection. Methods A total of 46801 inpatients from July toDecember2020were selected as the pre-intervention group, and the 45007 inpatients from July to December 2021 as the post-intervention group. The transparent supervision model was implemented in the hospital real-time monitoring system for the early-warning of CRKP strains. By means of information technology, the CRKP detection rate and discovery rateare transparently disclosed, and the implementation rate of core prevention The effects of transparent supervision before and after intervention were observed. Results After intervention, the infection rate of CRKP decreased from1.81‰to1.02‰（P<0.001;the detection rate of CRKP decreased from 29.42% to17.98% (P<0.001) The utilization rate of carbapenems exhibiting and ecreasing trend(P<0.05) Conclusion The implantation of transparent supervision modelin the hospital infection real-time monitoring system and timely early-warning of CKP cases caneffectively reduce the transmission of CRKP inhospital cross-infection.
关键词	透明监管；耐碳青霉烯肺炎克雷伯菌；感染控制；时间序列；合理用药
KeyWord	Transparent supervision; Carbapenem Resistant Klebsiella Pneumoniae；infection Prevention and control measures ; time series ; rational drug use
基金项目
页码	76-81

参考文献
相关文献

[1] Hammoudi Halat D,Ayoub Moubareck C.The current burden of carbapenemases:review of significant properties and dissemination among Gram negative bacteria
[J].Antibiotics(Basel)/2020.9(4):186
[2] Porreca A M,Sullivan K V.Gallagher J C. The epidemiology evolution and treatment of KPC-Producing organisms
[J].Curr infect Dis Rep,2018,20(6):13
[3] Satlin M J,Chen L,Patel G,et al. Multicenter clinical and molecular epidemiological analysis ofbacteremia due to carbapenem-resistant Enterobacteriaceae(CRE) (CRE) in the CRE Epicenter of the united States
[J].Antimicrob Agents Chemother,2017,61(4)e02349-16
[4] World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriacea , Acine to bacteria baumannii and Pseudomonas aeruginosa in health care facilities.(2017-11)
[2019-02-13].https://www.who.int/infection-prevention/publications/guidelines-CRKP/en/.
[5] Gysin DV,Cookso B,Saenz H,et al.Variability in contactprecautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting:a multinational cross-sectional survey.Antimicrob Resist Infect Control,2018,7:81.21
[6] Liu L,Feng Y,Tang G, et al. Carbapenem-resistant isolates of the Klebsiella pneumoniae complex in Western China: the common ST11 and the surprising hospital-specific types ClinInfect Dis, 2018, 67(suppl_2): S263-S265. 26
[7] Shu LB, Lu Q, Sun RH, t al. Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumonia strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China.Infect Drug Resist,2018,12:11-18.
[8] Dehmer GJ, Drozda JP Jr,Brindis RG,et al. Public reporting of clinical quality data:an updatefor cardiovascular specialists
[J].J AmColl Cardiol,2014, 63(13):1239-1245.DOI:10.1016/ j.jacc.2013.11.050.
[9] Passaretti C L, Barclay P, Pronovost P, et al. Public reporting of health care-associated infections(HCAIs)：approach to choosing HCAI measures
[J].Infect control Hosp Epidemiol,2011,32(8):768-774
[10] Box GE,Jenkins GM,Reinsel GC,etal.Time series analysis: forecasting and control
[M].JohnWiley amp; Sons, 2015.
[11] Feng C, Li J, Sun W, et al. Impact of ambient fine particulate matter (PM2.5) exposure on the risk of in fluenza-like-illness: a time-series analysis in Beijing, China
[J]. Environ Health, 2016,15:17.
[12] Wang T, Liu J, Zhou Y, et al. Prevalence of hemorrhagic fever with renal syndrome in Yiyuan County, China, 2005-2014
[J]. BMC Infect Dis, 2016, 16: 69.
[13] Song X, Xiao J, Deng J, et al. Time series analysis of influenza incidence in Chinese provinces from 2004 to 2011
[J]. Medicine (Baltimore), 2016, 95(26): e3929.
[14] Tomczyk S, Zanichelli V, Grayson ML,et al. Control of Carbapenem-resistant Enterobacteriaceae,Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities:A Systematic Review and Reanalysis of Quasi-experimental Studies. Clin Infect Dis.2019 Feb15; 68(5):873-884.
[15] van Loon k,voor in holt AF,Vos MC.a systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacterianceae
[J].Antimicrob Agents chemother,2018,62:e01730-17
[16] Daikos G L,T saousi S,Tzouvelekis LS,et al. Carbapenemase producing blood stream infections: lowering mortality antibiotic combination schemes and the role of carbapenems
[J].Antimicrob Agents chemother,2014,58(4):2322-2328
[17] Chea N, Bulens SN, Kongphet-Tran T, et al. Improved phenotype-based definition for identifying carbapenemase producers among CRE. Emerg Infect Dis 2015; 21:1611-6.
[18] Hayden MK, Lin MY, Lolans K, et al. Prevention of colonization and infection by KPC-producing Enter bacteriaceae in long term acute-care hospitals. Clin Infect Dis 2015;60:1153-61.

引用本文

吴晓琴*,石理冉,路全胜,郭风,阚红侠. 基于信息化的透明监管对耐碳青霉烯肺炎克雷伯菌医院感染的影响：时间序列分析 [J]. 国际临床研究杂志. 2022; 6; (9). 76 - 81.

文献评论

相关学者

相关机构